GRANULES INDIA LIMITED INDIA

Granules India Limited is a factory.

Company Introduction:

Granules India Limited is a prominent Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). Established in 1991 and headquartered in Hyderabad, India, the company has evolved into a key player in the global pharmaceutical landscape. Granules India operates state-of-the-art manufacturing facilities that adhere to stringent international regulatory standards, supplying pharmaceutical products to customers in over 80 countries worldwide. The company is known for its vertically integrated business model, which encompasses the entire production process from raw materials to finished goods, emphasizing quality, efficiency, and cost-effectiveness. Granules India is dedicated to innovation, research and development, and maintaining high standards of quality across all its operations.

GRANULES INDIA LIMITED INDIA manufactures and sells a range of pharmaceutical products across Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs).

Their product portfolio includes key molecules in various therapeutic areas:

Pain Management

Paracetamol (Acetaminophen)

Ibuprofen

Diabetes Management

Metformin HCl

Cough and Cold

Guaifenesin

Muscle Relaxants

Methocarbamol

Anti-Allergics

Cetirizine

Fexofenadine

Gastrointestinal

Ranitidine HCl

Famotidine

Omeprazole

Pantoprazole

Domperidone

Cardiovascular

Clopidogrel

Rosuvastatin

Valsartan

Amlodipine

Atorvastatin

Central Nervous System (CNS)

Sertraline

Levetiracetam

This list represents some of their prominent offerings, encompassing a broad spectrum of therapeutic categories in different forms for pharmaceutical manufacturing and direct patient use.